About this trial
The prospective study LOCATION MATTERS aims to investigate the radiation-induced damage to the heart and the cardiovascular system in patients treated with thoracic radiotherapy. Patients enrolled in the study will complete a set of extensive measures at the baseline, end of RT, and 9 months after treatment. Ultrasound exams, CT scans, pulmonary tests and wearable devices will assess functional and morphological parameters and the association with their variation and the dose delivered to the heart substructures and to the normal lung.
Eligibility criteria
Qualifiers
Patients with NSCLC
Patients with locally advanced disease (Stage 3)
Patients treated with RT at Fondazione IRCCS Istituto Nazionale dei Tumori
Disqualifiers
Previous thoracic radiotherapy
Previous heart surgery
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Lead sponsor
Politecnico di Milano
Collaborator